PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds
NCT04351191
First Published (first received 2020)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT04351191)
Trial registry recordNo Results
To treat Pakistani patients with non-life threatening symptomatic SARS-CoV-2 infection with
an intent to reduce burden on institutional healthcare services by determining efficacy of
different chloroquine and hydroxychloroquine dosing regimens in controlling SARS-CoV-2
infection